• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

4.360 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
September 15, 2023
 
Via Benzinga
News headline image
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga
News headline image
Nasdaq Down Over 1%; US Industrial Output Rises In August ↗
September 15, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The... 
Via Benzinga
Topics Stocks
News headline image
Where Iovance Biotherapeutics Stands With Analysts ↗
September 13, 2023
 
Via Benzinga
News headline image
Expert Ratings for Iovance Biotherapeutics ↗
August 09, 2023
 
Via Benzinga
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is One of Friday Morning’s Most Active Stocks
September 15, 2023
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
September 15, 2023
 
Via Benzinga
News headline image
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket ↗
September 15, 2023
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday. 
Via Benzinga
News headline image
Mitek Systems, Arm Holdings And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗
September 15, 2023
U.S. stock futures traded mostly higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma
September 14, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Why Shares of Iovance Biotherapeutics Dropped Thursday ↗
September 14, 2023
The biotech stock's lead therapy is looking at some competition. 
Via The Motley Fool
News headline image
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
September 14, 2023
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi. 
Via Benzinga
News headline image
Iovance Biotherapeutics Stock Is Down 15%: What's Going On? ↗
September 14, 2023
Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading lower by 15.8% to $4.58, despite a lack of company-specific news for the session. 
Via Benzinga
News headline image
Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference
September 07, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗
August 28, 2023
Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook. 
Via InvestorPlace
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 18, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates
August 08, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock ↗
August 02, 2023
 
Via Benzinga
News headline image
Cathie Wood Buys $3.4M Worth Of Shares In This Payments Software Firm — Also Increases Exposure To Iridium Stock ↗
August 01, 2023
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Sells Robinhood, Coinbase Shares — Buys $3.5M Worth Of Stock Of This Social Media Company ↗
July 31, 2023
 
Via Benzinga
News headline image
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick ↗
July 31, 2023
For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly. 
Via InvestorPlace
News headline image
Cathie Wood's Ark Invest Continues To Sell Shares Of Warren Buffett-Backed BYD — Coinbase Holdings Trimmed As Well ↗
July 26, 2023
 
Via Benzinga
News headline image
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer
July 25, 2023
Oral Presentation of Cohort 3A Data from IOV-COM-202 Phase 2 Clinical Trial of LN-145 in Combination with Pembrolizumab in Anti-PD1-naïve Advanced (metastatic or unresectable) Non-Small Cell Lung... 
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, August 8, 2023
July 24, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 21, 2023
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering
July 13, 2023
Offering Includes Exercise in Full of the Underwriters’ Option to Purchase an Additional 3 Million Shares of Common Stock 
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
July 11, 2023
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday. 
Via Benzinga
News headline image
Why Iovance Biotherapeutics Stock Is Dropping Tuesday ↗
July 11, 2023
The company is doing a $150 million public stock offering. 
Via The Motley Fool
News headline image
DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership ↗
July 11, 2023
Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk. 
Via InvestorPlace
News headline image
Why Is Zillow (Z) Stock Up 8% Today? ↗
July 11, 2023
Zillow (Z) stock is on the rise Tuesday after the tech real-estate marketplace company's shares got an upgrade from Piper Sandler. 
Via InvestorPlace
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap